SCHEMBL22317249

SCHEMBL22317249

C=C(CCC)C(=O)c1ccc(OC)c(Cl)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 11/20 0.56
▸ GSTA1 P08263 5/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ LMNA P02545 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ ABCC3 O15438 1/20 0.56
▸ PLIN1 O60240 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ HSPD1 P10809 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ MAP2K6 P52564 1/20 0.56
▸ HSPE1 P61604 1/20 0.56
▸ GSTO1 P78417 1/20 0.56
▸ PLIN5 Q00G26 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ ATM Q13315 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10659730 0.88 GSTP1 (0.52) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL13284005 0.88 GSTP1 (0.70) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL11656296 0.85 GSTP1 (0.52) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL10001217 0.83 GSTP1 (0.81) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL11603324 0.81 THRB (0.52) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL9717498 0.81 GSTP1 (0.62) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL10678567 0.80 GSTP1 (0.51) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL11451833 0.80 GSTP1 (0.48) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL9717542 0.79 GSTP1 (0.53) GSTP1GSTA1ALDH1A1LMNAMEN1
SCHEMBL9717561 0.78 GSTP1 (0.48) GSTP1GSTA1ALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11000492-B2 Fluorenone compound for the treatment of gout THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-05-11 — — US disclosed
US-20200246289-A1 FLUORENONE COMPOUND FOR THE TREATMENT OF GOUT THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11000492-B2 Fluorenone compound for the treatment of gout SLC10A1, PCSK9, PCSK7 GSTP1 1344/4885GSTA1 826/4885ALDH1A1 1105/4885
US-20200246289-A1 FLUORENONE COMPOUND FOR THE TREATMENT OF GOUT SLC10A1, PCSK9, PCSK7 GSTP1 1344/4885GSTA1 826/4885ALDH1A1 1105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback